25 XP   0   0   10

C-Rad AB (publ)
Buy, Hold or Sell?

Let's analyse C-rad together

PenkeI guess you are interested in C-Rad AB (publ). Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of C-Rad AB (publ). At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about C-Rad AB (publ)

I send you an email if I find something interesting about C-Rad AB (publ).

Quick analysis of C-rad (30 sec.)










What can you expect buying and holding a share of C-rad? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr8.34
Expected worth in 1 year
kr9.50
How sure are you?
62.5%

+ What do you gain per year?

Total Gains per Share
kr1.16
Return On Investment
2.9%

For what price can you sell your share?

Current Price per Share
kr40.10
Expected price per share
kr37.50 - kr46.15
How sure are you?
50%

1. Valuation of C-rad (5 min.)




Live pricePrice per Share (EOD)

kr40.10

Intrinsic Value Per Share

kr19.30 - kr69.47

Total Value Per Share

kr27.64 - kr77.81

2. Growth of C-rad (5 min.)




Is C-rad growing?

Current yearPrevious yearGrowGrow %
How rich?$25.6m$21.5m$2.1m9.2%

How much money is C-rad making?

Current yearPrevious yearGrowGrow %
Making money$1m$170.5k$878.2k83.7%
Net Profit Margin9.7%1.6%--

How much money comes from the company's main activities?

3. Financial Health of C-rad (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#198 / 339

Most Revenue
#194 / 339

Most Profit
#99 / 339

What can you expect buying and holding a share of C-rad? (5 min.)

Welcome investor! C-rad's management wants to use your money to grow the business. In return you get a share of C-rad.

What can you expect buying and holding a share of C-rad?

First you should know what it really means to hold a share of C-rad. And how you can make/lose money.

Speculation

The Price per Share of C-rad is kr40.10. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of C-rad.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in C-rad, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr8.34. Based on the TTM, the Book Value Change Per Share is kr0.29 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.37 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of C-rad.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.070.2%0.030.1%0.000.0%0.010.0%0.000.0%
Usd Book Value Change Per Share0.060.1%0.030.1%0.030.1%0.030.1%0.020.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.060.1%0.030.1%0.030.1%0.030.1%0.020.0%
Usd Price Per Share3.85-3.03-3.64-3.71-2.73-
Price to Earnings Ratio13.44-41.84--90.54-25.83-28.29-
Price-to-Total Gains Ratio67.52-198.84-426.19--33.42--3.07-
Price to Book Ratio5.06-4.30-5.73-7.76-9.52-
Price-to-Total Gains Ratio67.52-198.84-426.19--33.42--3.07-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.65712
Number of shares273
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.030.03
Usd Total Gains Per Share0.030.03
Gains per Quarter (273 shares)7.206.83
Gains per Year (273 shares)28.7827.32
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10291902717
20584805544
30867708271
40115106010998
501441350137125
601731640164152
702011930191179
802302220219206
902592510246233
1002882800273260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%10.02.00.083.3%14.06.00.070.0%19.021.00.047.5%19.044.00.030.2%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%16.04.00.080.0%25.015.00.062.5%31.030.02.049.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.063.00.0%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%16.04.00.080.0%25.015.00.062.5%31.030.02.049.2%

Fundamentals of C-rad

About C-Rad AB (publ)

C-Rad AB (publ), together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. Its products include Sentinel 4DCT, a laser-based optical surface scanning system; Catalyst, a 4D surface image guided radiation therapy (SIGRT) solution; Catalyst HD, an SIGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst+, an SIGRT solution for high precision patient positioning, intra-fraction motion management, and respiratory gating; and Catalyst+ HD, a solution for high precision patient positioning, intra-fraction motion management, and respiratory gating for conventional and stereotactic treatment delivery. The company's products also comprise of StaticPhantom, a set-up used to visually verify the precision of the alignment of lasers; Catalyst PT, a real-time tracking solution for particle therapy; cAccessory, which automates the registration and validation of treatment accessories; cAutoVerify, a automation solution for the imaging suite and treatment room, automating patient identity validation, and accessory tracking, and Visual Coaching Solutions used for prospective and retrospective radiotherapy. In addition, it offers support and training services. The company was incorporated in 2004 and is headquartered in Uppsala, Sweden.

Fundamental data was last updated by Penke on 2024-03-30 09:58:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of C-Rad AB (publ).

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit C-rad earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare C-rad to the Medical Devices industry mean.
  • A Net Profit Margin of 19.1% means that kr0.19 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of C-Rad AB (publ):

  • The MRQ is 19.1%. The company is making a huge profit. +2
  • The TTM is 9.7%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ19.1%TTM9.7%+9.5%
TTM9.7%YOY1.6%+8.1%
TTM9.7%5Y3.7%+6.0%
5Y3.7%10Y-6.8%+10.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ19.1%-11.2%+30.3%
TTM9.7%-19.6%+29.3%
YOY1.6%-14.4%+16.0%
5Y3.7%-21.3%+25.0%
10Y-6.8%-24.8%+18.0%
1.1.2. Return on Assets

Shows how efficient C-rad is using its assets to generate profit.

  • Above 5% is considered healthy but always compare C-rad to the Medical Devices industry mean.
  • 6.6% Return on Assets means that C-rad generated kr0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of C-Rad AB (publ):

  • The MRQ is 6.6%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 3.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.6%TTM3.0%+3.6%
TTM3.0%YOY0.6%+2.4%
TTM3.0%5Y1.0%+2.0%
5Y1.0%10Y-1.3%+2.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.6%-4.0%+10.6%
TTM3.0%-4.5%+7.5%
YOY0.6%-4.8%+5.4%
5Y1.0%-4.0%+5.0%
10Y-1.3%-5.2%+3.9%
1.1.3. Return on Equity

Shows how efficient C-rad is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare C-rad to the Medical Devices industry mean.
  • 9.4% Return on Equity means C-rad generated kr0.09 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of C-Rad AB (publ):

  • The MRQ is 9.4%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 4.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ9.4%TTM4.3%+5.2%
TTM4.3%YOY0.8%+3.5%
TTM4.3%5Y1.1%+3.1%
5Y1.1%10Y-2.6%+3.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ9.4%-3.9%+13.3%
TTM4.3%-5.6%+9.9%
YOY0.8%-5.9%+6.7%
5Y1.1%-6.1%+7.2%
10Y-2.6%-7.1%+4.5%

1.2. Operating Efficiency of C-Rad AB (publ).

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient C-rad is operating .

  • Measures how much profit C-rad makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare C-rad to the Medical Devices industry mean.
  • An Operating Margin of 21.5% means the company generated kr0.22  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of C-Rad AB (publ):

  • The MRQ is 21.5%. The company is operating efficient. +1
  • The TTM is 13.6%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ21.5%TTM13.6%+7.9%
TTM13.6%YOY6.4%+7.2%
TTM13.6%5Y7.0%+6.6%
5Y7.0%10Y-7.0%+14.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ21.5%-22.8%+44.3%
TTM13.6%-17.1%+30.7%
YOY6.4%-13.4%+19.8%
5Y7.0%-19.2%+26.2%
10Y-7.0%-24.0%+17.0%
1.2.2. Operating Ratio

Measures how efficient C-rad is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.78 means that the operating costs are kr0.78 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of C-Rad AB (publ):

  • The MRQ is 0.785. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.864. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.785TTM0.864-0.080
TTM0.864YOY0.937-0.072
TTM0.8645Y0.925-0.061
5Y0.92510Y1.080-0.155
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7851.428-0.643
TTM0.8641.426-0.562
YOY0.9371.503-0.566
5Y0.9251.440-0.515
10Y1.0801.371-0.291

1.3. Liquidity of C-Rad AB (publ).

1.3. Liquidity
1.3.1. Current Ratio

Measures if C-rad is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.01 means the company has kr3.01 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of C-Rad AB (publ):

  • The MRQ is 3.011. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.197. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.011TTM3.197-0.186
TTM3.197YOY3.811-0.614
TTM3.1975Y3.370-0.173
5Y3.37010Y2.958+0.412
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0112.787+0.224
TTM3.1972.763+0.434
YOY3.8113.488+0.323
5Y3.3703.617-0.247
10Y2.9583.514-0.556
1.3.2. Quick Ratio

Measures if C-rad is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare C-rad to the Medical Devices industry mean.
  • A Quick Ratio of 2.19 means the company can pay off kr2.19 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of C-Rad AB (publ):

  • The MRQ is 2.192. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.538. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.192TTM2.538-0.346
TTM2.538YOY3.376-0.838
TTM2.5385Y2.969-0.430
5Y2.96910Y1.989+0.980
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1921.539+0.653
TTM2.5381.660+0.878
YOY3.3762.139+1.237
5Y2.9692.300+0.669
10Y1.9892.255-0.266

1.4. Solvency of C-Rad AB (publ).

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of C-rad assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare C-rad to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.30 means that C-rad assets are financed with 30.3% credit (debt) and the remaining percentage (100% - 30.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of C-Rad AB (publ):

  • The MRQ is 0.303. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.290. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.303TTM0.290+0.013
TTM0.290YOY0.251+0.040
TTM0.2905Y0.2910.000
5Y0.29110Y0.340-0.049
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3030.389-0.086
TTM0.2900.386-0.096
YOY0.2510.338-0.087
5Y0.2910.442-0.151
10Y0.3400.460-0.120
1.4.2. Debt to Equity Ratio

Measures if C-rad is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare C-rad to the Medical Devices industry mean.
  • A Debt to Equity ratio of 43.5% means that company has kr0.43 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of C-Rad AB (publ):

  • The MRQ is 0.435. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.410. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.435TTM0.410+0.024
TTM0.410YOY0.335+0.075
TTM0.4105Y0.433-0.023
5Y0.43310Y0.554-0.121
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4350.559-0.124
TTM0.4100.560-0.150
YOY0.3350.478-0.143
5Y0.4330.624-0.191
10Y0.5540.674-0.120

2. Market Valuation of C-Rad AB (publ)

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings C-rad generates.

  • Above 15 is considered overpriced but always compare C-rad to the Medical Devices industry mean.
  • A PE ratio of 13.44 means the investor is paying kr13.44 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of C-Rad AB (publ):

  • The EOD is 12.774. Based on the earnings, the company is underpriced. +1
  • The MRQ is 13.443. Based on the earnings, the company is underpriced. +1
  • The TTM is 41.842. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD12.774MRQ13.443-0.669
MRQ13.443TTM41.842-28.399
TTM41.842YOY-90.538+132.380
TTM41.8425Y25.832+16.009
5Y25.83210Y28.288-2.456
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD12.774-1.037+13.811
MRQ13.443-1.578+15.021
TTM41.842-2.041+43.883
YOY-90.538-2.971-87.567
5Y25.832-2.058+27.890
10Y28.288-1.463+29.751
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of C-Rad AB (publ):

  • The EOD is 6.677. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.026. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 0.557. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD6.677MRQ7.026-0.350
MRQ7.026TTM0.557+6.469
TTM0.557YOY-38.659+39.217
TTM0.5575Y-247.632+248.190
5Y-247.63210Y-133.473-114.159
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD6.677-1.007+7.684
MRQ7.026-1.544+8.570
TTM0.557-3.018+3.575
YOY-38.659-6.339-32.320
5Y-247.632-4.928-242.704
10Y-133.473-4.950-128.523
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of C-rad is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 5.06 means the investor is paying kr5.06 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of C-Rad AB (publ):

  • The EOD is 4.808. Based on the equity, the company is fair priced.
  • The MRQ is 5.060. Based on the equity, the company is overpriced. -1
  • The TTM is 4.301. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.808MRQ5.060-0.252
MRQ5.060TTM4.301+0.759
TTM4.301YOY5.730-1.429
TTM4.3015Y7.763-3.462
5Y7.76310Y9.520-1.757
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD4.8081.987+2.821
MRQ5.0602.379+2.681
TTM4.3012.444+1.857
YOY5.7303.215+2.515
5Y7.7633.833+3.930
10Y9.5204.163+5.357
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of C-Rad AB (publ) compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.6250.289+116%0.373+67%0.274+128%0.180+248%
Book Value Per Share--8.3407.685+9%6.984+19%5.892+42%3.804+119%
Current Ratio--3.0113.197-6%3.811-21%3.370-11%2.958+2%
Debt To Asset Ratio--0.3030.290+4%0.251+21%0.291+4%0.340-11%
Debt To Equity Ratio--0.4350.410+6%0.335+30%0.433+0%0.554-22%
Dividend Per Share----0%-0%-0%-0%
Eps--0.7850.340+131%0.053+1372%0.115+581%0.021+3666%
Free Cash Flow Per Share--1.5010.160+838%0.073+1963%0.088+1606%-0.050+103%
Free Cash Flow To Equity Per Share--1.4780.119+1145%0.055+2580%0.206+619%0.101+1361%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--69.469--------
Intrinsic Value_10Y_min--19.299--------
Intrinsic Value_1Y_max--1.370--------
Intrinsic Value_1Y_min--0.163--------
Intrinsic Value_3Y_max--8.377--------
Intrinsic Value_3Y_min--2.026--------
Intrinsic Value_5Y_max--20.522--------
Intrinsic Value_5Y_min--5.559--------
Market Cap1315901550.000-8%1424964657.0001123585837.363+27%1348714676.200+6%1379440897.713+3%1005647700.731+42%
Net Profit Margin--0.1910.097+98%0.016+1120%0.037+414%-0.068+136%
Operating Margin--0.2150.136+58%0.064+238%0.070+206%-0.070+133%
Operating Ratio--0.7850.864-9%0.937-16%0.925-15%1.080-27%
Pb Ratio4.808-5%5.0604.301+18%5.730-12%7.763-35%9.520-47%
Pe Ratio12.774-5%13.44341.842-68%-90.538+773%25.832-48%28.288-52%
Price Per Share40.100-5%42.20033.188+27%39.875+6%40.633+4%29.888+41%
Price To Free Cash Flow Ratio6.677-5%7.0260.557+1161%-38.659+650%-247.632+3624%-133.473+2000%
Price To Total Gains Ratio64.161-5%67.522198.837-66%426.194-84%-33.420+149%-3.074+105%
Quick Ratio--2.1922.538-14%3.376-35%2.969-26%1.989+10%
Return On Assets--0.0660.030+120%0.006+1065%0.010+576%-0.013+119%
Return On Equity--0.0940.043+121%0.008+1143%0.011+749%-0.026+127%
Total Gains Per Share--0.6250.289+116%0.373+67%0.274+128%0.180+248%
Usd Book Value--25681920.00023732520.000+8%21537883.200+19%18208795.920+41%11682324.130+120%
Usd Book Value Change Per Share--0.0570.026+116%0.034+67%0.025+128%0.016+248%
Usd Book Value Per Share--0.7610.701+9%0.637+19%0.537+42%0.347+119%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0720.031+131%0.005+1372%0.011+581%0.002+3666%
Usd Free Cash Flow--4623840.000490200.000+843%223212.000+1972%274881.360+1582%-144431.306+103%
Usd Free Cash Flow Per Share--0.1370.015+838%0.007+1963%0.008+1606%-0.005+103%
Usd Free Cash Flow To Equity Per Share--0.1350.011+1145%0.005+2580%0.019+619%0.009+1361%
Usd Market Cap120010221.360-8%129956776.718102471028.367+27%123002778.469+6%125805009.871+3%91715070.307+42%
Usd Price Per Share3.657-5%3.8493.027+27%3.637+6%3.706+4%2.726+41%
Usd Profit--2416800.0001048800.000+130%170521.200+1317%360449.760+570%70017.658+3352%
Usd Revenue--12622080.0009680880.000+30%6870232.800+84%6448296.000+96%4421831.811+185%
Usd Total Gains Per Share--0.0570.026+116%0.034+67%0.025+128%0.016+248%
 EOD+4 -4MRQTTM+25 -8YOY+25 -85Y+27 -610Y+31 -2

3.2. Fundamental Score

Let's check the fundamental score of C-Rad AB (publ) based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1512.774
Price to Book Ratio (EOD)Between0-14.808
Net Profit Margin (MRQ)Greater than00.191
Operating Margin (MRQ)Greater than00.215
Quick Ratio (MRQ)Greater than12.192
Current Ratio (MRQ)Greater than13.011
Debt to Asset Ratio (MRQ)Less than10.303
Debt to Equity Ratio (MRQ)Less than10.435
Return on Equity (MRQ)Greater than0.150.094
Return on Assets (MRQ)Greater than0.050.066
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of C-Rad AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.335
Ma 20Greater thanMa 5040.663
Ma 50Greater thanMa 10042.912
Ma 100Greater thanMa 20042.531
OpenGreater thanClose40.050
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income Tax Expense  1,8061,2943,100-1,3001,8006,1007,900-9,600-1,700



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets404,000
Total Liabilities122,400
Total Stockholder Equity281,700
 As reported
Total Liabilities 122,400
Total Stockholder Equity+ 281,700
Total Assets = 404,000

Assets

Total Assets404,000
Total Current Assets363,100
Long-term Assets40,900
Total Current Assets
Cash And Cash Equivalents 129,400
Net Receivables 135,000
Inventory 64,100
Other Current Assets 34,600
Total Current Assets  (as reported)363,100
Total Current Assets  (calculated)363,100
+/- 0
Long-term Assets
Property Plant Equipment 10,600
Intangible Assets 30,100
Other Assets 0
Long-term Assets  (as reported)40,900
Long-term Assets  (calculated)40,700
+/- 200

Liabilities & Shareholders' Equity

Total Current Liabilities120,600
Long-term Liabilities1,800
Total Stockholder Equity281,700
Total Current Liabilities
Accounts payable 29,700
Other Current Liabilities 90,900
Total Current Liabilities  (as reported)120,600
Total Current Liabilities  (calculated)120,600
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)1,800
Long-term Liabilities  (calculated)0
+/- 1,800
Total Stockholder Equity
Total Stockholder Equity (as reported)281,700
Total Stockholder Equity (calculated)0
+/- 281,700
Other
Cash and Short Term Investments 129,400
Common Stock Shares Outstanding 33,767
Liabilities and Stockholders Equity 404,000
Net Debt -127,600
Net Working Capital 242,500
Short Long Term Debt Total 1,800



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-31
> Total Assets 
0
0
0
48,383
42,911
38,974
40,464
44,837
53,728
67,819
66,221
67,820
60,013
50,777
49,438
54,204
47,054
40,881
35,969
38,125
39,746
59,652
58,111
61,772
66,222
68,612
65,681
72,663
68,585
80,546
69,012
73,625
80,368
86,819
91,901
102,102
99,837
107,274
110,000
118,056
111,300
124,000
117,300
146,614
157,900
178,200
176,600
157,792
243,000
229,300
252,900
270,523
272,100
278,500
285,400
306,707
301,500
308,400
312,900
339,174
337,100
346,500
381,700
404,000
404,000381,700346,500337,100339,174312,900308,400301,500306,707285,400278,500272,100270,523252,900229,300243,000157,792176,600178,200157,900146,614117,300124,000111,300118,056110,000107,27499,837102,10291,90186,81980,36873,62569,01280,54668,58572,66365,68168,61266,22261,77258,11159,65239,74638,12535,96940,88147,05454,20449,43850,77760,01367,82066,22167,81953,72844,83740,46438,97442,91148,383000
   > Total Current Assets 
0
0
0
21,362
13,942
8,326
9,429
12,552
19,787
31,837
29,972
29,365
21,111
11,665
10,825
35,164
26,916
22,835
18,731
21,771
15,185
36,358
29,466
32,770
37,386
32,897
29,470
36,004
32,271
42,515
28,980
33,957
41,508
47,954
53,307
64,583
62,380
69,930
72,700
80,412
73,500
86,500
80,700
90,276
99,200
108,400
118,500
109,307
193,900
184,600
201,800
215,839
221,200
228,200
238,000
264,083
260,500
270,700
281,600
307,125
304,000
313,400
342,400
363,100
363,100342,400313,400304,000307,125281,600270,700260,500264,083238,000228,200221,200215,839201,800184,600193,900109,307118,500108,40099,20090,27680,70086,50073,50080,41272,70069,93062,38064,58353,30747,95441,50833,95728,98042,51532,27136,00429,47032,89737,38632,77029,46636,35815,18521,77118,73122,83526,91635,16410,82511,66521,11129,36529,97231,83719,78712,5529,4298,32613,94221,362000
       Cash And Cash Equivalents 
0
0
0
16,349
9,777
5,307
7,215
3,981
12,225
24,324
19,004
19,376
11,801
4,110
2,361
24,600
15,811
10,596
5,393
7,961
3,304
20,812
7,348
10,262
15,356
10,711
4,568
7,623
2,364
10,969
4,634
4,426
6,569
15,487
5,730
12,683
15,196
9,101
17,900
14,594
5,500
6,300
8,000
9,333
26,800
27,500
30,200
29,485
87,900
83,200
94,000
108,045
111,600
114,100
111,000
122,420
115,500
108,300
95,600
121,896
105,200
82,600
89,800
129,400
129,40089,80082,600105,200121,89695,600108,300115,500122,420111,000114,100111,600108,04594,00083,20087,90029,48530,20027,50026,8009,3338,0006,3005,50014,59417,9009,10115,19612,6835,73015,4876,5694,4264,63410,9692,3647,6234,56810,71115,35610,2627,34820,8123,3047,9615,39310,59615,81124,6002,3614,11011,80119,37619,00424,32412,2253,9817,2155,3079,77716,349000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31,719
44,022
48,000
43,512
48,700
68,900
61,000
67,487
62,300
71,600
79,100
61,999
89,300
83,600
87,100
79,167
88,500
97,500
115,500
119,451
119,100
132,700
152,500
145,200
152,100
181,700
164,500
135,000
135,000164,500181,700152,100145,200152,500132,700119,100119,451115,50097,50088,50079,16787,10083,60089,30061,99979,10071,60062,30067,48761,00068,90048,70043,51248,00044,02231,719000000000000000000000000000000000000
       Other Current Assets 
0
0
0
3,819
3,141
2,301
2,044
6,278
5,325
5,482
9,559
7,502
7,196
4,781
4,735
6,533
7,576
7,541
8,154
10,670
7,797
9,551
16,441
18,403
15,644
17,804
16,082
20,349
19,682
19,078
13,694
19,188
26,132
21,833
39,306
45,540
41,330
54,643
48,000
45,717
48,700
68,900
61,000
69,280
62,300
71,700
79,100
64,870
89,300
83,600
87,100
82,092
88,500
97,500
115,500
124,441
119,100
132,700
152,500
0
0
-100
34,200
34,600
34,60034,200-10000152,500132,700119,100124,441115,50097,50088,50082,09287,10083,60089,30064,87079,10071,70062,30069,28061,00068,90048,70045,71748,00054,64341,33045,54039,30621,83326,13219,18813,69419,07819,68220,34916,08217,80415,64418,40316,4419,5517,79710,6708,1547,5417,5766,5334,7354,7817,1967,5029,5595,4825,3256,2782,0442,3013,1413,819000
   > Long-term Assets 
0
0
0
27,022
28,969
30,648
31,035
32,285
33,941
35,982
36,249
38,455
38,902
39,112
38,613
19,040
20,138
18,046
17,238
16,354
24,561
23,294
28,645
29,002
28,836
35,714
36,211
36,659
36,314
38,031
40,032
39,669
38,860
38,864
38,594
37,520
37,457
37,344
37,300
37,644
37,800
37,500
36,600
56,338
58,700
69,800
58,100
48,485
49,100
44,700
51,100
54,684
50,900
50,300
47,500
42,624
41,000
37,700
31,300
32,049
33,200
33,100
39,300
40,900
40,90039,30033,10033,20032,04931,30037,70041,00042,62447,50050,30050,90054,68451,10044,70049,10048,48558,10069,80058,70056,33836,60037,50037,80037,64437,30037,34437,45737,52038,59438,86438,86039,66940,03238,03136,31436,65936,21135,71428,83629,00228,64523,29424,56116,35417,23818,04620,13819,04038,61339,11238,90238,45536,24935,98233,94132,28531,03530,64828,96927,022000
       Property Plant Equipment 
0
0
0
407
348
402
607
580
578
587
752
693
730
681
571
815
2,876
1,733
1,863
2,756
3,188
3,254
3,248
3,294
3,033
2,752
2,948
4,057
3,752
4,561
4,875
4,583
4,225
4,392
4,727
3,337
2,980
2,679
2,400
2,142
1,900
1,600
1,300
1,275
4,400
15,100
5,000
4,908
4,700
4,300
11,900
13,043
12,400
12,300
13,400
12,588
12,000
11,100
11,000
10,106
8,600
7,600
9,300
10,600
10,6009,3007,6008,60010,10611,00011,10012,00012,58813,40012,30012,40013,04311,9004,3004,7004,9085,00015,1004,4001,2751,3001,6001,9002,1422,4002,6792,9803,3374,7274,3924,2254,5834,8754,5613,7524,0572,9482,7523,0333,2943,2483,2543,1882,7561,8631,7332,876815571681730693752587578580607402348407000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,492
12,281
10,990
12,124
12,380
12,710
12,939
12,961
12,243
12,590
13,068
27,908
27,839
27,435
27,272
26,617
26,982
27,277
27,465
27,700
28,307
28,700
28,700
28,100
26,887
26,300
26,500
27,500
17,835
18,800
17,900
17,900
17,867
17,700
17,500
17,300
16,951
17,300
18,300
19,000
21,716
24,600
26,100
29,400
30,100
30,10029,40026,10024,60021,71619,00018,30017,30016,95117,30017,50017,70017,86717,90017,90018,80017,83527,50026,50026,30026,88728,10028,70028,70028,30727,70027,46527,27726,98226,61727,27227,43527,83927,90813,06812,59012,24312,96112,93912,71012,38012,12410,99012,28113,4920000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
71,429
0
0
0
0
0
79,337
77,719
0
0
0
28,751
29,180
7,200
31,521
7,200
7,200
7,200
51,846
28,000
28,200
25,600
40,015
25,600
22,500
21,300
38,830
20,700
20,500
16,700
28,929
11,700
8,300
1,300
300
-100
-600
600
0
0600-600-1003001,3008,30011,70028,92916,70020,50020,70038,83021,30022,50025,60040,01525,60028,20028,00051,8467,2007,2007,20031,5217,20029,18028,75100077,71979,3370000071,4290000000000000000000000000
> Total Liabilities 
0
0
0
13,334
10,287
9,286
9,425
15,020
15,135
15,180
14,338
19,704
17,100
16,497
19,054
18,189
18,348
17,686
18,244
21,861
29,531
20,570
19,961
23,744
19,655
18,780
19,651
32,626
32,148
25,107
22,829
33,577
49,872
25,171
37,940
31,500
35,000
45,970
51,700
46,649
45,000
55,600
48,100
52,971
63,000
81,500
80,100
74,458
55,600
43,500
62,600
70,734
63,700
64,700
65,800
75,617
70,900
77,200
72,600
96,630
91,200
94,600
120,200
122,400
122,400120,20094,60091,20096,63072,60077,20070,90075,61765,80064,70063,70070,73462,60043,50055,60074,45880,10081,50063,00052,97148,10055,60045,00046,64951,70045,97035,00031,50037,94025,17149,87233,57722,82925,10732,14832,62619,65118,78019,65523,74419,96120,57029,53121,86118,24417,68618,34818,18919,05416,49717,10019,70414,33815,18015,13515,0209,4259,28610,28713,334000
   > Total Current Liabilities 
0
0
0
9,061
4,859
3,823
2,928
8,019
7,099
5,573
4,809
11,159
8,508
7,859
10,369
8,329
8,428
7,723
8,202
12,566
14,986
8,408
7,218
12,238
7,977
7,194
8,024
15,958
15,389
13,358
9,695
20,755
21,715
12,460
25,365
19,029
22,555
33,649
51,400
46,649
45,000
55,600
48,100
52,973
39,800
48,800
60,000
54,159
54,900
42,700
55,300
63,298
56,700
57,300
58,800
69,243
64,900
71,800
68,000
92,555
88,100
92,300
116,800
120,600
120,600116,80092,30088,10092,55568,00071,80064,90069,24358,80057,30056,70063,29855,30042,70054,90054,15960,00048,80039,80052,97348,10055,60045,00046,64951,40033,64922,55519,02925,36512,46021,71520,7559,69513,35815,38915,9588,0247,1947,97712,2387,2188,40814,98612,5668,2027,7238,4288,32910,3697,8598,50811,1594,8095,5737,0998,0192,9283,8234,8599,061000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,892
0
0
0
0
0
0
0
12,443
12,324
300
300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000030030012,32412,44300000002,8920000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,443
12,324
300
300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000030030012,32412,443000000000000000000000000000000000000
       Accounts payable 
0
0
0
1,125
0
0
0
4,760
0
0
0
4,744
0
0
0
2,569
0
0
0
3,050
0
0
0
3,712
4,007
2,635
3,652
6,635
6,394
6,496
4,747
9,014
6,741
5,955
11,138
7,582
6,923
6,005
0
8,289
0
0
0
9,321
0
0
0
11,604
0
0
0
17,071
0
0
0
22,641
0
0
0
31,007
0
0
40,100
29,700
29,70040,1000031,00700022,64100017,07100011,6040009,3210008,28906,0056,9237,58211,1385,9556,7419,0144,7476,4966,3946,6353,6522,6354,0073,7120003,0500002,5690004,7440004,7600001,125000
       Other Current Liabilities 
0
0
0
7,936
4,859
3,823
2,928
3,259
7,099
5,573
4,809
6,415
8,508
7,859
10,369
5,760
8,428
7,723
8,202
9,517
14,986
8,408
7,218
8,526
3,970
4,559
4,372
9,323
6,103
6,862
4,948
11,742
14,974
6,505
14,227
11,447
15,632
27,644
51,400
38,360
45,000
55,600
48,100
43,652
39,800
48,800
60,000
42,555
54,900
42,700
55,300
46,227
56,700
57,300
58,800
46,602
64,900
71,800
68,000
61,548
88,100
92,300
76,700
90,900
90,90076,70092,30088,10061,54868,00071,80064,90046,60258,80057,30056,70046,22755,30042,70054,90042,55560,00048,80039,80043,65248,10055,60045,00038,36051,40027,64415,63211,44714,2276,50514,97411,7424,9486,8626,1039,3234,3724,5593,9708,5267,2188,40814,9869,5178,2027,7238,4285,76010,3697,8598,5086,4154,8095,5737,0993,2592,9283,8234,8597,936000
   > Long-term Liabilities 
0
0
0
4,273
5,428
5,463
6,497
7,001
8,036
9,607
9,529
8,545
8,592
8,638
8,685
9,859
9,920
9,963
10,042
9,295
14,545
12,162
12,743
11,506
11,678
11,587
11,627
16,667
16,759
11,748
13,134
12,822
28,157
12,711
12,575
12,471
12,445
12,321
300
0
0
0
0
-2
23,200
32,700
20,100
20,299
700
800
7,300
7,436
7,000
7,400
7,000
6,374
6,000
5,400
4,600
4,075
3,100
2,300
3,400
1,800
1,8003,4002,3003,1004,0754,6005,4006,0006,3747,0007,4007,0007,4367,30080070020,29920,10032,70023,200-2000030012,32112,44512,47112,57512,71128,15712,82213,13411,74816,75916,66711,62711,58711,67811,50612,74312,16214,5459,29510,0429,9639,9209,8598,6858,6388,5928,5459,5299,6078,0367,0016,4975,4635,4284,273000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,436
7,000
7,300
7,100
6,400
6,000
5,300
4,500
4,100
3,200
2,400
3,400
0
03,4002,4003,2004,1004,5005,3006,0006,4007,1007,3007,0007,436000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
-1
0
0
0
0
0
0
20,100
20,000
20,000
20,000
0
0
0
0
0
100
-100
0
0
100
100
0
0
0
0
0
0000010010000-1001000000020,00020,00020,00020,100000000-12000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,551
21,980
0
24,325
0
0
0
23,669
0
0
0
14,271
0
0
0
15,056
0
0
0
15,844
0
0
0
0
0
0
0
0
0000000015,84400015,05600014,27100023,66900024,325021,98021,551000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
35,049
32,624
29,688
31,039
29,816
38,593
52,639
51,883
48,117
42,913
34,280
30,384
36,015
28,706
23,195
17,725
16,264
10,215
39,082
38,150
38,028
46,567
49,831
46,030
40,038
36,436
55,439
46,182
40,048
30,496
61,647
53,961
70,602
64,837
61,304
58,300
71,407
66,300
68,400
69,200
93,643
94,900
96,700
96,500
83,334
187,400
185,800
190,300
199,789
208,400
213,800
219,600
231,090
230,600
231,200
240,300
242,544
245,900
251,900
261,500
281,700
281,700261,500251,900245,900242,544240,300231,200230,600231,090219,600213,800208,400199,789190,300185,800187,40083,33496,50096,70094,90093,64369,20068,40066,30071,40758,30061,30464,83770,60253,96161,64730,49640,04846,18255,43936,43640,03846,03049,83146,56738,02838,15039,08210,21516,26417,72523,19528,70636,01530,38434,28042,91348,11751,88352,63938,59329,81631,03929,68832,62435,049000
   Common Stock
0
0
0
1,428
0
0
0
1,496
0
0
0
1,845
0
0
0
2,380
0
0
0
2,380
0
0
0
2,937
3,042
3,042
3,042
3,042
3,042
3,304
3,304
3,304
3,304
4,130
4,130
4,430
4,430
4,430
58,300
4,614
66,300
68,400
69,200
4,614
94,900
96,700
96,500
4,653
187,400
185,800
190,300
5,049
0
213,800
219,600
5,063
230,600
231,200
240,300
5,065
245,900
251,900
261,500
0
0261,500251,900245,9005,065240,300231,200230,6005,063219,600213,80005,049190,300185,800187,4004,65396,50096,70094,9004,61469,20068,40066,3004,61458,3004,4304,4304,4304,1304,1303,3043,3043,3043,3043,0423,0423,0423,0423,0422,9370002,3800002,3800001,8450001,4960001,428000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
271,440
0
0
0
0
0
0
0
380,455
0
0
0
0
0
0
0
0
00000000380,4550000000271,44000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
56,988
0
0
0
61,896
0
0
0
89,618
0
0
0
119,500
0
0
0
119,402
0
0
0
161,223
171,993
120,128
175,159
171,332
171,919
169,559
115,230
193,979
192,996
233,015
234,107
255,230
254,092
254,467
0
264,730
0
0
0
267,803
0
0
0
271,255
187,400
185,800
190,300
372,949
208,400
213,800
219,600
379,134
230,600
231,200
240,300
383,107
245,900
251,900
261,500
0
0261,500251,900245,900383,107240,300231,200230,600379,134219,600213,800208,400372,949190,300185,800187,400271,255000267,803000264,7300254,467254,092255,230234,107233,015192,996193,979115,230169,559171,919171,332175,159120,128171,993161,223000119,402000119,50000089,61800061,89600056,988000



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue424,600
Cost of Revenue-358,600
Gross Profit66,00066,000
 
Operating Income (+$)
Gross Profit66,000
Operating Expense-3,800
Operating Income62,20062,200
 
Operating Expense (+$)
Research Development3,800
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense3,8003,800
 
Net Interest Income (+$)
Interest Income262
Interest Expense-400
Other Finance Cost-66
Net Interest Income-72
 
Pretax Income (+$)
Operating Income62,200
Net Interest Income-72
Other Non-Operating Income Expenses0
Income Before Tax (EBT)57,20067,200
EBIT - interestExpense = 61,800
57,200
46,500
Interest Expense400
Earnings Before Interest and Taxes (EBIT)62,20057,600
Earnings Before Interest and Taxes (EBITDA)67,300
 
After tax Income (+$)
Income Before Tax57,200
Tax Provision-14,706
Net Income From Continuing Ops23,98042,494
Net Income46,100
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses362,400
Total Other Income/Expenses Net-5,00072
 

Technical Analysis of C-rad
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of C-rad. The general trend of C-rad is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine C-rad's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of C-Rad AB (publ).

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 40.35 < 40.40 < 46.15.

The bearish price targets are: 38.25 > 37.90 > 37.50.

Tweet this
C-Rad AB (publ) Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of C-Rad AB (publ). The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

C-Rad AB (publ) Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of C-Rad AB (publ). The current macd is -0.95670757.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the C-rad price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for C-rad. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the C-rad price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
C-Rad AB (publ) Daily Moving Average Convergence/Divergence (MACD) ChartC-Rad AB (publ) Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of C-Rad AB (publ). The current adx is 17.79.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell C-rad shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
C-Rad AB (publ) Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of C-Rad AB (publ). The current sar is 41.44.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
C-Rad AB (publ) Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of C-Rad AB (publ). The current rsi is 45.34. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
C-Rad AB (publ) Daily Relative Strength Index (RSI) ChartC-Rad AB (publ) Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of C-Rad AB (publ). The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the C-rad price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
C-Rad AB (publ) Daily Stochastic Oscillator ChartC-Rad AB (publ) Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of C-Rad AB (publ). The current cci is -50.26536976.

C-Rad AB (publ) Daily Commodity Channel Index (CCI) ChartC-Rad AB (publ) Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of C-Rad AB (publ). The current cmo is -2.18776844.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
C-Rad AB (publ) Daily Chande Momentum Oscillator (CMO) ChartC-Rad AB (publ) Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of C-Rad AB (publ). The current willr is -54.21686747.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that C-rad is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
C-Rad AB (publ) Daily Williams %R ChartC-Rad AB (publ) Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of C-Rad AB (publ).

C-Rad AB (publ) Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of C-Rad AB (publ). The current atr is 1.28793304.

C-Rad AB (publ) Daily Average True Range (ATR) ChartC-Rad AB (publ) Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of C-Rad AB (publ). The current obv is 367,570.

C-Rad AB (publ) Daily On-Balance Volume (OBV) ChartC-Rad AB (publ) Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of C-Rad AB (publ). The current mfi is 26.72.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
C-Rad AB (publ) Daily Money Flow Index (MFI) ChartC-Rad AB (publ) Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for C-Rad AB (publ).

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-31BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-13MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

C-Rad AB (publ) Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of C-Rad AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.335
Ma 20Greater thanMa 5040.663
Ma 50Greater thanMa 10042.912
Ma 100Greater thanMa 20042.531
OpenGreater thanClose40.050
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of C-rad with someone you think should read this too:
  • Are you bullish or bearish on C-rad? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about C-rad? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about C-Rad AB (publ)

I send you an email if I find something interesting about C-Rad AB (publ).


Comments

How you think about this?

Leave a comment

Stay informed about C-Rad AB (publ).

Receive notifications about C-Rad AB (publ) in your mailbox!